Medical innovation versus stem cell tourism.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19556497.
- Also identified by DOI 10.1126/science.1171749.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stem cell tourism is criticized on grounds of consumer fraud, blatant lack of scientific justification, and patient safety. However, the issues are complex because they invoke questions concerning the limits of acceptable medical innovation and medical travel. Here we discuss these issues and articulate conditions under which "unproven" therapies may be offered to patients outside of regular clinical trials.
Medical subject headings
- Clinical Trials as Topic
- Delivery of Health Care
- Stem Cell Transplantation
- Therapies, Investigational
- Travel